Ixico cheers FDA approval for contractor Fujirebio's Alzheimer's test
(Alliance News) - Ixico PLC on Tuesday hailed regulatory approval for a new Alzheimer's test, which it was contracted to analyse during clinical trials. Read More
Price | 11.75p on 18-06-2025 | at 18:50:07
---|---|
Change | 0.00p 0% |
Buy | 12.00p |
Sell | 11.50p |
Buy / Sell IXI Shares |
Last Trade: | Sell 2,500.00 at 11.55p |
Day's Volume: | 11,524 |
Last Close: | 11.75p |
Open: | 11.75p |
ISIN: | GB00BFXR4C20 |
Day's Range | 11.75p - 11.75p |
52wk Range: | 6.60p - 13.50p |
Market Capitalisation: | £11m |
VWAP: | 11.80311p |
Shares in Issue: | 93m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Ixico (IXI) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|---|---|---|---|
Sell* | 2,500 | 11.55p | Ordinary |
15:27:16 - 18-Jun-25 |
Sell* | 85 | 11.55p | Ordinary |
12:23:33 - 18-Jun-25 |
Buy* | 422 | 11.88p | Ordinary |
11:32:45 - 18-Jun-25 |
Buy* | 8,417 | 11.88p | Ordinary |
09:43:03 - 18-Jun-25 |
Sell* | 100 | 11.55p | Ordinary |
08:04:38 - 18-Jun-25 |
Sell* | 1,400 | 11.55p | Ordinary |
10:55:22 - 17-Jun-25 |
Sell* | 2,083 | 11.50p | SI Trade |
11:02:48 - 16-Jun-25 |
Buy* | 7,000 | 11.89p | Ordinary |
09:56:19 - 16-Jun-25 |
Buy* | 8,410 | 11.89p | Ordinary |
09:56:18 - 16-Jun-25 |
Sell* | 3,000 | 11.10p | Ordinary |
08:59:32 - 16-Jun-25 |
Ixico (IXI) Regulatory News |
||
Date | Source | Headline |
---|---|---|
13th Jun 2025 8:03 am | RNS | Share option awards and PDMR Dealing |
10th Jun 2025 7:00 am | RNS | FDA Clearance of Alzheimer's Diagnostic Biomarker |
20th May 2025 6:00 pm | RNS | Holding(s) in Company |
20th May 2025 7:00 am | RNS | Half-year Report |
8th May 2025 11:30 am | RNS | Holding(s) in Company |
6th May 2025 7:00 am | RNS | Notice of Interim Results & Investor Presentation |
16th Apr 2025 7:00 am | RNS | Trading Update |
27th Feb 2025 7:00 am | RNS | Contract Win |
12th Feb 2025 7:00 am | RNS | Further Validation of IXICO’s AI Imaging Platform |
7th Feb 2025 3:00 pm | RNS | Issue of share options and PDMR dealing |